Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
about
Alzheimer mechanisms and therapeutic strategiesSouvenaid for Alzheimer's diseaseMini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studiesAlzheimer disease: new concepts on its neurobiology and the clinical role imaging will playToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersWhat can imaging tell us about cognitive impairment and dementia?Olfactory dysfunction in Alzheimer's diseaseSuspected non-Alzheimer disease pathophysiology--concept and controversyFacilitating the Validation of Novel Protein Biomarkers for Dementia: An Optimal Workflow for the Development of Sandwich ImmunoassaysNanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseCurrent Developments in Dementia Risk Prediction Modelling: An Updated Systematic ReviewThe impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal VariationPathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body diseaseScience to practice: translating automated brain MRI volumetry in Alzheimer's disease from research to routine diagnostic use in the work-up of dementiaA practical algorithm for managing Alzheimer's disease: what, when, and why?Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic CriteriaAlzheimer's disease in African Americans: risk factors and challenges for the futureCognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessmentPractical diagnosis and management of dementia due to Alzheimer's disease in the primary care setting: an evidence-based approachHarmonized diagnostic criteria for Alzheimer's disease: recommendationsBrain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogsAn algorithmic approach to structural imaging in dementiaHow are we going to live with Alzheimer's disease?Can the DSM-5 framework enhance the diagnosis of MCI?Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's diseaseMemory loss in Alzheimer's diseaseEarly detection of Alzheimer's disease using MRI hippocampal textureStructural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future PerspectivesOcular indicators of Alzheimer's: exploring disease in the retinaDementia: timely diagnosis and early interventionAlzheimer's disease: Unique markers for diagnosis & new treatment modalitiesGenetic variants in Alzheimer disease - molecular and brain network approachesAdvancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational SummitThe diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseThe diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseasePathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisAlzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.
P2860
Q22252311-91EDD76B-FA43-47CA-B19B-4FF0D40BDD8AQ24188326-B2DD4078-A637-4DA9-A481-5EA5AC94F8A1Q24197659-ADF60EBB-18D1-4882-A375-EA896DFCFB8BQ24200257-8ACDD0A1-E9FC-49C0-B402-FDF0249283FFQ24594531-D02DA7B3-AD16-40E4-ABC8-FC7AFD64051FQ24595802-B1348800-02BF-40DC-96DE-AE166E8FC6A7Q26745508-21C9D57A-F862-4503-A9D4-57EE01290CC3Q26749292-CD5E4230-11E2-458C-B600-83904D502A90Q26752969-7F89F39F-D0F7-437C-97AA-C88E22D57ED8Q26771270-CEDD67DD-2D2B-4F7C-8C96-39A5C9531474Q26781562-A9EB3232-2581-4CC9-9848-EE56D36DD4E0Q26783306-651B9247-1CBE-45FE-8A33-F35A0A96235FQ26786212-7EA9CE62-539E-447A-AB82-E54150D02A38Q26801634-11CD0EC4-A329-44BA-8B07-2C6857112275Q26801663-DAD91FA6-5FFC-45AA-A303-588A035002D7Q26853610-C77486B0-ACF1-449E-A221-072A662D0475Q26859565-472EA8B2-19CC-4114-9ACC-311A8A808377Q26859831-F7E5BC1E-F3BF-446D-9B09-F59F5058C465Q26864063-07A0539F-AB54-49B0-96DD-379093840589Q26991696-419AB8F9-4160-4A06-B66A-DC583DEF34BDQ27003324-53EA4BAE-A343-43DA-880C-0251721A022CQ27006895-C292FD47-888A-4EF6-B164-5925897AFB24Q27009157-A4279F82-17D9-4372-B492-2230C15C5C01Q27012801-4736CFA8-18F6-44F5-A767-3B8AE553D134Q27025567-1D09EE6C-1DDC-4FF9-9F89-D48F8A2B12F0Q27025608-E98C284B-9A39-4941-A785-189F8981B9ADQ27026677-9AD8DC96-69A9-4E66-A4E7-2DCFD15515C9Q27309046-53B3772D-4E2A-4E98-B6EB-EB488B0A3BA6Q27687485-D6CFA147-1BC7-4230-8EA2-70791C251598Q27907796-D461E1F7-EF4A-45E2-BED8-922F6C47E199Q28077809-1A456E42-3218-4255-AEC9-8032A567EF8FQ28078670-AEA5C426-BB2D-403F-A3F6-0B7EA8D24F0EQ28082444-37CB60AA-BD58-48E4-9A26-F6693A152CCBQ28085139-43948145-C42F-4155-90EA-56364A04FEA7Q28596011-4D28159E-8157-4964-8E49-5ECE296CCAB2Q28709591-BA849B16-561C-4C36-8A72-8D1AC59B36E2Q29547554-F85378A1-6DBD-4A37-B44B-EB8712301D03Q29614406-EA218470-2AA6-4385-A25F-46458B507AFFQ30235369-3EC348D3-0BF5-4906-B5BC-44EEB16FD553Q30244736-B3F7F808-EF04-4ABF-BBD7-CBD3CAD7E17B
P2860
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Introduction to the recommenda ...... lines for Alzheimer's disease.
@ast
Introduction to the recommenda ...... lines for Alzheimer's disease.
@en
Introduction to the recommenda ...... lines for Alzheimer's disease.
@nl
type
label
Introduction to the recommenda ...... lines for Alzheimer's disease.
@ast
Introduction to the recommenda ...... lines for Alzheimer's disease.
@en
Introduction to the recommenda ...... lines for Alzheimer's disease.
@nl
prefLabel
Introduction to the recommenda ...... lines for Alzheimer's disease.
@ast
Introduction to the recommenda ...... lines for Alzheimer's disease.
@en
Introduction to the recommenda ...... lines for Alzheimer's disease.
@nl
P2093
P2860
P50
P1476
Introduction to the recommenda ...... lines for Alzheimer's disease.
@en
P2093
Bill Thies
Creighton H Phelps
Guy M McKhann
Marilyn S Albert
Reisa A Sperling
P2860
P304
P356
10.1016/J.JALZ.2011.03.004
P407
P577
2011-04-21T00:00:00Z